Breast Cancer

Showing 49–68 of 68 results

Olanib 150 mg Tablet

Molecule : OlaparibManufacturer : Everest Pharma

Olanib 50 mg Capsule

Molecule : OlaparibManufacturer : Everest Pharma

Palboxen 125 mg Capsule

Molecule : PalbociclibManufacturer : Everest Pharma

Palnat 100 mg Capsule

Molecule : PalbociclibManufacturer : Natco Pharma
Palnat 100 mg Capsule contains Palbociclib, a targeted oral anticancer medicine used in the treatment of hormone receptor–positive (HR+), HER2-negative

Palnat 125 mg Capsule

Molecule : PalbociclibManufacturer : Natco Pharma
Palnat 125 mg Capsule contains Palbociclib, a CDK4/6 inhibitor used in combination with hormonal therapies for the treatment of HR-positive,

Perjeta 420 mg Injection

Molecule : PertuzumabManufacturer : Roche
Perjeta Pertuzumab 420mg Injection are manufactured by Roche Products India Pvt Ltd in India and contain 420 mg of Pertuzumab

Phesgo Injection

Molecule : PertuzumabManufacturer : Roche

Ribotix 200 mg Tablet

Molecule : RibociclibManufacturer : Beacon Pharma

Tecentriq 1200 mg Injection

Molecule : AtezolizumabManufacturer : Roche

Trodelvy 180 mg Vial

Molecule : Sacituzumab GovitecanManufacturer : Gilead
Trodelvy 180 mg Vial contains Sacituzumab Govitecan, an advanced targeted cancer therapy classified as an antibody-drug conjugate (ADC). It is

Truqap 200 mg Tablet

Molecule : CapivasertibManufacturer : Astrazeneca

Tucanat 150 mg Tablet

Molecule : TucatinibManufacturer : Natco Pharma

Tucaxen 150 mg Tablet

Molecule : TucatinibManufacturer : Everest Pharma

Tukysa 150 mg Tablet

Molecule : TucatinibManufacturer : Seagen
(1)
TUKYSA® (tucatinib) is an FDA-approved oral medication used to treat adults with certain types of HER2-positive metastatic breast cancer and HER2-positive, RAS wild-type metastatic colorectal cancer. It is a tyrosine kinase inhibitor (TKI) that targets HER2 protein signaling inside cancer cells, offering patients a well-tolerated and effective non-chemotherapy option — including those with brain metastases.

Tykerb 250 mg Tablet

Molecule : LapatinibManufacturer : Novartis
Tykerb 250 mg Tablets are manufactured by NOVARTIS INDIA LTD in United Kingdom and contain 250 mg of Lapatinib per

Verzenio 50 mg Tablet

Molecule : AbemaciclibManufacturer : Eli Lilly And Company

Vinelbine 10 mg Injection

Molecule : VinorelbineManufacturer : Fresenius Kabi

Vinelbine 50 mg Injection

Molecule : VinorelbineManufacturer : Fresenius Kabi

Vitrakvi 100 mg Capsule

Molecule : LarotrectinibManufacturer : Bayer Zydus Pharma Pvt Ltd

Xtane 25 mg Tablet

Molecule : ExemestaneManufacturer : Natco Pharma
Xtane 25mg Tablet contains Exemestane, a hormonal therapy used to treat hormone receptor–positive breast cancer in postmenopausal women. It lowers